Bone loss at lumbar spine after kidney transplant reduced with IV pamidronate
Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplantOsteoporos Int. 2011 Jan;22(1):281-7
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
39 patients with ostepenia and who underwent a kidney transplant were enrolled in this study to determine if the administration of intravenous pamidronate postoperatively improved bone mineral density (BMD). BMD, skeletal fractures and bone remodeling were analyzed one year after the transplant to evaluate the effects of intravenous bisphophonates. Patients who received the pamidronate demonstrate...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue